The purpose of this study is to determine the minimum effective dose of sugammadex, an
antagonist of neuromuscular blockade used during anesthesia practice, in obese patients,
considering that sugammadex is indicated in adults with normal weight at a dose of 2 mg/kg
but no studies were found with obese patients.
Phase:
Phase 4
Details
Lead Sponsor:
Faculdade de Ciências Médicas da Santa Casa de São Paulo